Pharm’Aging promotes Inserm patents in anti-aging care!

Pharm’Aging valorise des brevets de l’Inserm dans des soins anti-âge !

Pharm’Aging has an exclusive solution to prevent skin aging: a family of anti-aging molecules resulting from fifteen years of research carried out within the Agir laboratory, jointly between Inserm and the CNRS, at the Amiens University Hospital. Mastered by SATT Nord, a technology transfer acceleration company, this work was enhanced last December by the transfer of a license for three patents to Doctor Nicolas El Robrini, founder of this start-up based in Marseille since the beginning 2019.

#innovation  #proprieteintellectuelle #sattnord #inserm #pharmaging #brevets # pimotion #piplanner